WILLF (Demant AS) Change In Receivables : $-18 Mil (TTM As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Demant AS Change In Receivables?

Demant AS's change in receivables for the quarter that ended in Dec. 2024 was $27 Mil. It means Demant AS's Accounts Receivable declined by $27 Mil from Jun. 2024 to Dec. 2024 .

Demant AS's change in receivables for the fiscal year that ended in Dec. 2024 was $-17 Mil. It means Demant AS's Accounts Receivable increased by $17 Mil from Dec. 2023 to Dec. 2024 .

Demant AS's Accounts Receivable for the quarter that ended in Dec. 2024 was $500 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Demant AS's Days Sales Outstanding for the six months ended in Dec. 2024 was 57.38.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Demant AS's liquidation value for the six months ended in Dec. 2024 was $-2,495 Mil.

Demant AS Change In Receivables Historical Data

The historical data trend for Demant AS's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Demant AS Change In Receivables Chart

Demant AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

43.50

-72.03

-69.91

-23.12

-16.71

Demant AS Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Receivables	Get a 7-Day Free Trial															10.25	-45.84	22.97	-45.29	27.38

Demant AS Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-18 Mil.

Demant AS (OTCPK:WILLF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Demant AS's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	500.274	/	1591.104	*	91
=	57.38

2. In Ben Graham's calculation of liquidation value, Demant AS's accounts receivable are only considered to be worth 75% of book value:

Demant AS's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	156.134	-	3202.145	+	0.75 * 500.274	+	0.5 * 351.02
=	-2,495

Demant AS Change In Receivables Related Terms

Thank you for viewing the detailed overview of Demant AS's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Demant AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Demant AS (OTCPK:WILLF) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

WILYY:USA DEMANc:UK 0RGT:UK DEMANT:Denmark WDH1:Germany DEMA:Austria

Address

Kongebakken 9, Smorum, DNK, 2765

Website

https://www.demant.com

Demant AS is a Denmark-based company engaged in the healthcare industry. The company develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments. The Company operates through more than 90 subsidiaries and associates all around the world. More than 80% of the company's sales come from North America and Europe.